Literature DB >> 2246325

Growth factor-induced DNA synthesis in cells that overproduce protein kinase C.

S Hoshina1, M Ueffing, I B Weinstein.   

Abstract

In previous studies (Housey et al.: Cell 52:343-354, 1988), our laboratory demonstrated that a cell line R6-PKC3 that stably overproduces high levels of the beta 1 isoform of PKC displayed several abnormalities in growth control, and these phenotypic changes were also markedly enhanced when the cells were exposed to TPA. The present studies indicate that these cells also display marked changes in their response to certain growth factors. A striking finding was that several agents when tested alone in serum-free medium, including EGF, PDGF, TPA, teleocidin, and OAG, stimulated DNA synthesis in quiescent R6-PKC3 cells but had a negligible effect in quiescent R6-C1 cells, a vector control cell line with normal levels of PKC. R6-PKC3 cells also show an exaggerated response to very low concentrations of serum, when compared to R6-C1 control cells. These studies provide direct genetic evidence that alterations in cellular levels of PKC can markedly influence the responses of cells to specific growth factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246325     DOI: 10.1002/jcp.1041450210

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  3 in total

1.  PKC isoenzyme expression and cellular responses to phorbol ester in JEG-3 choriocarcinoma cells.

Authors:  A M Bamberger; C M Bamberger; M Wald; K Jensen; H M Schulte
Journal:  Endocrine       Date:  1997-04       Impact factor: 3.633

2.  Endothelin-1 activates phospholipase D and thymidine incorporation in fibroblasts overexpressing protein kinase C beta 1.

Authors:  J K Pai; E A Dobek; W R Bishop
Journal:  Cell Regul       Date:  1991-11

3.  Novel revertants of H-ras oncogene-transformed R6-PKC3 cells.

Authors:  R S Krauss; S N Guadagno; I B Weinstein
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.